Assertio Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
/ 
Frequently asked questions
To buy Assertio Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Assertio Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Assertio Holdings Inc. is ASRT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Assertio Holdings Inc. has its primary listing on NASDAQ. You can trade Assertio Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Assertio Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Assertio Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Assertio Holdings Inc..